EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Re: real world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting gram-negative bacilli infections: author's response

Baptiste Hoellinger, François Danion, Yves Hansmann, Frederic Schramm, Yvon Ruch

Clinical Microbiology and Infection · 2023

DOI: 10.1016/j.cmi.2023.02.019 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Microbiology and Infection, 2023. Verfasst von Baptiste Hoellinger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Electronic address: baptiste.hoellinger@ch…. Hauptthemen laut MEDLINE: Cephalosporins, Gram-Negative Bacterial Infections. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CephalosporinsGram-Negative Bacterial InfectionsHumansGram-Negative BacteriaAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsCefiderocol

Substanzen

CephalosporinsAnti-Bacterial AgentsCefiderocol

Autor:innen und Institutionen

  • Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Electronic address: baptiste.hoellinger@chru-strasbourg.fr.
  • Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Department of Bacteriology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Zitieren

APA

Hoellinger, B., Danion, F., Hansmann, Y., Schramm, F., & Ruch, Y. (2023). Re: real world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting gram-negative bacilli infections: author's response. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.02.019

Vancouver

Hoellinger B, Danion F, Hansmann Y, Schramm F, Ruch Y. Re: real world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting gram-negative bacilli infections: author's response. Clinical Microbiology and Infection. 2023. doi:10.1016/j.cmi.2023.02.019

BibTeX
@article{Hoellinger2023,
  author = {Hoellinger, Baptiste and Danion, François and Hansmann, Yves and Schramm, Frederic and Ruch, Yvon},
  title = {Re: real world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting gram-negative bacilli infections: author's response},
  journal = {Clinical Microbiology and Infection},
  year = {2023},
  doi = {10.1016/j.cmi.2023.02.019}
}
Kostenlos starten →